REFERENCES
Alsulaimani, R.S. (2018). Immediate and Delayed Repair of 2 Sizes of Furcal Perforations in Dogs’ Teeth Using Mineral Trioxide Aggregate Cement. J Endod . 44(6), 1000-1006. 10.1016/j.joen.2018.02.026
Ashbaugh, D.G., Bigelow, D.B., Petty, T.L., & Levine, B.E. (1967). Acute respiratory distress in adults. Lancet . 2(7511), 319-323. 10.1016/s0140-6736(67)90168-7
Ashino, S., Takeda, K., Li, H., Taylor, V., Joetham, A., Pine, P.R., & Gelfand, E.W. (2014). Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses.Journal of Allergy & Clinical Immunology . 133(4), 1162-1174.
Aslan, A.T., & Akova, M. (2021). Current status of therapeutic alternatives for COVID-19: A narrative review. Infez Med . 29(3), 312-327. 10.53854/liim-2903-2
Bachofen, M., & Weibel, E.R. (1982). Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med . 3(1), 35-56.
Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D.M. (2017). JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Drugs . 77(5), 521-546. 10.1007/s40265-017-0701-9
Beaulieu, D., Attwe, A., Breau, M., Lipskaia, L., & Adnot, S. (2021). Phospholipase A2-Receptor 1 Promotes Lung-Cell Senescence and Emphysema in Obstructive Lung Disease. European Respiratory Journal , 2000752.
Betz, A., & Darnell, J.J. (2006). A Hopscotch-chromatin connection. Nat Genet . 38(9), 977-979. 10.1038/ng0906-977
Bhattacharya, J., & Matthay, M.A. (2013). Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annu Rev Physiol . 75, 593-615. 10.1146/annurev-physiol-030212-183756
Bhavsar, S.K., Hosseinzadeh, Z., Brenner, D., Honisch, S., Jilani, K., & Liu, G., et al. (2014). Energy-sensitive regulation of Na+/K+-ATPase by Janus kinase 2. Am J Physiol Cell Physiol . 306(4), C374-C384. 10.1152/ajpcell.00320.2013
Birukova, A.A., Tian, Y., Meliton, A., Leff, A., Wu, T., & Birukov, K.G. (2012). Stimulation of Rho signaling by pathologic mechanical stretch is a ”second hit” to Rho-independent lung injury induced by IL-6. Am J Physiol Lung Cell Mol Physiol . 302(9), L965-L975. 10.1152/ajplung.00292.2011
Borghouts, C., Tittmann, H., Delis, N., Kirchenbauer, M., Brill, B., & Groner, B. (2010). The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death. Mol Cancer Res . 8(4), 539-553. 10.1158/1541-7786.MCR-09-0417
Bosch-Barrera, J., Martin-Castillo, B., Buxo, M., Brunet, J., Encinar, J.A., & Menendez, J.A. (2020). Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. J Clin Med . 9(6). 10.3390/jcm9061770
Bousquet, C., Susini, C., & Melmed, S. (1999). Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor. J Clin Invest . 104(9), 1277-1285. 10.1172/JCI7924
Bringué, J., Guillamat-Prats, R., Martinez, M.L., Torrents, E., Camprubí-Rimblas, M., Blanch, L., & Artigas, A. (2021). Methotrexate Ameliorates Systemic Inflammation and Septic Associated-Lung Damage in a Cecal Ligation and Puncture Septic Rat Model. International Journal of Molecular Sciences . 22(17), 9612. 10.3390/ijms22179612
Buchert, M., Burns, C.J., & Ernst, M. (2016). Targeting JAK kinase in solid tumors: emerging opportunities and challenges. Oncogene . 35(8), 939-951. 10.1038/onc.2015.150
Cai, B., Cai, J.P., Luo, Y.L., Chen, C., & Zhang, S. (2015). The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.Inflammation . 38(4), 1599-1608. 10.1007/s10753-015-0135-z
Cetkovic-Cvrlje, M., & Uckun, F.M. (2004). Targeting Janus kinase 3 in the treatment of leukemia and inflammatory diseases. Archivum Immunologiae et Therapiae Experimentalis . 52(2), 69-82.
Chen, C.X., Wang, J.J., Li, H., Yuan, L.T., Gale, R.P., & Liang, Y. (2021). JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis. Leukemia . 35(9), 2616-2620. 10.1038/s41375-021-01266-6
Chung, C.D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997). Specific inhibition of Stat3 signal transduction by PIAS3.Science . 278(5344), 1803-1805. 10.1126/science.278.5344.1803
Coffey, G., Betz, A., DeGuzman, F., Pak, Y., Inagaki, M., & Baker, D.C., et al. (2014). The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer.J Pharmacol Exp Ther . 351(3), 538-548. 10.1124/jpet.114.218164
Convertino, I., Tuccori, M., Ferraro, S., Valdiserra, G., Cappello, E., Focosi, D., & Blandizzi, C. (2020). Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients. Crit Care . 24(1), 331. 10.1186/s13054-020-03020-3
Coon, T.A., McKelvey, A.C., Lear, T., Rajbhandari, S., Dunn, S.R., & Connelly, W., et al. (2015). The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Sci Transl Med . 7(295), 109r-295r. 10.1126/scitranslmed.aab3881
Cooney, R.N. (2002). Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock . 17(2), 83-90. 10.1097/00024382-200202000-00001
Damera, G., Xia, B., & Sach De V, G.P. (2006). IL-4 induced MUC4 enhancement in respiratory epithelial cells in vitro is mediated through JAK-3 selective signaling. Respiratory Research . 7(1), 39.
Dodington, D.W., Desai, H.R., & Woo, M. (2018). JAK/STAT - Emerging Players in Metabolism. Trends Endocrinol Metab . 29(1), 55-65. 10.1016/j.tem.2017.11.001
Endo, T.A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., & Mitsui, K., et al. (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature . 387(6636), 921-924. 10.1038/43213
Fan, S., He, J., Yang, Y., & Wang, D. (2021). Intermedin Reduces Oxidative Stress and Apoptosis in Ventilator-Induced Lung Injury via JAK2/STAT3.Front Pharmacol . 12, 817874. 10.3389/fphar.2021.817874
Favalli, E.G., Biggioggero, M., Maioli, G., & Caporali, R. (2020). Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis . 20(9), 1012-1013. 10.1016/S1473-3099(20)30262-0
Files, D.C., Sanchez, M.A., & Morris, P.E. (2015). A conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome. Crit Care . 19, 266. 10.1186/s13054-015-0979-5
Gadina, M., Johnson, C., Schwartz, D., Bonelli, M., Hasni, S., & Kanno, Y., et al. (2018). Translational and clinical advances in JAK‐STAT biology: The present and future of jakinibs. Journal of leukocyte biology . 104(3), 499-514. 10.1002/JLB.5RI0218-084R
Gao, Q., Liang, X., Shaikh, A.S., Zang, J., Xu, W., & Zhang, Y. (2018). JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases. Curr Drug Targets . 19(5), 487-500. 10.2174/1389450117666161207163054
Ghoreschi, K., Laurence, A., & O’Shea, J.J. (2009). Janus kinases in immune cell signaling. Immunol Rev . 228(1), 273-287. 10.1111/j.1600-065X.2008.00754.x
Giudice, V., Pagliano, P., Vatrella, A., Masullo, A., Poto, S., & Polverino, B.M., et al. (2020). Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study. Front Pharmacol . 11, 857. 10.3389/fphar.2020.00857
Gu, T., Zhao, S., Jin, G., Song, M., Zhi, Y., & Zhao, R., et al. (2020). Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model. Front Immunol . 11, 621441. 10.3389/fimmu.2020.621441
Gudipaty, S.A., & Rosenblatt, J. (2017). Epithelial cell extrusion: Pathways and pathologies. Semin Cell Dev Biol . 67, 132-140. 10.1016/j.semcdb.2016.05.010
Guimaraes, P.O., Quirk, D., Furtado, R.H., Maia, L.N., Saraiva, J.F., & Antunes, M.O., et al. (2021). Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med . 385(5), 406-415. 10.1056/NEJMoa2101643
Guo, Y.R., Cao, Q.D., Hong, Z.S., Tan, Y.Y., Chen, S.D., & Jin, H.J., et al. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.Mil Med Res . 7(1), 11. 10.1186/s40779-020-00240-0
Hamvas, A., Nogee, L.M., White, F.V., Schuler, P., Hackett, B.P., & Huddleston, C.B., et al. (2004). Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol . 30(6), 771-776. 10.1165/rcmb.2003-0323OC
Hatzimichael, E., Tsolas, E., & Briasoulis, E. (2014). Profile of pacritinib and its potential in the treatment of hematologic disorders. J Blood Med . 5, 143-152. 10.2147/JBM.S51253
Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Muller-Newen, G., & Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J . 374(Pt 1), 1-20. 10.1042/BJ20030407
Hixson, K.M., Cogswell, M., Brooks-Kayal, A.R., & Russek, S.J. (2019). Evidence for a non-canonical JAK/STAT signaling pathway in the synthesis of the brain’s major ion channels and neurotransmitter receptors.BMC Genomics . 20(1), 677. 10.1186/s12864-019-6033-2
Hokenson, M.A., Wang, Y., Hawwa, R.L., Huang, Z., Sharma, S., & Sanchez-Esteban, J. (2013). Reduced IL-10 Production in Fetal Type II Epithelial Cells Exposed to Mechanical Stretch Is Mediated via Activation of IL-6-SOCS3 Signaling Pathway. Plos One . 8.
Hosseinzadeh, Z., Honisch, S., Schmid, E., Jilani, K., Szteyn, K., & Bhavsar, S., et al. (2015). The Role of Janus Kinase 3 in the Regulation of Na(+)/K(+) ATPase under Energy Depletion. Cell Physiol Biochem . 36(2), 727-740. 10.1159/000430133
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., & Welstead, G., et al. (2001). CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature . 409(6818), 349-354. 10.1038/35053086
Jamilloux, Y., El, J.T., Vuitton, L., Gerfaud-Valentin, M., Kerever, S., & Seve, P. (2019). JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev . 18(11), 102390. 10.1016/j.autrev.2019.102390
Jiang, Z., Chen, Z., Li, L., Zhou, W., & Zhu, L. (2017). Lack of SOCS3 increases LPS-induced murine acute lung injury through modulation of Ly6C(+) macrophages. Respir Res . 18(1), 217. 10.1186/s12931-017-0707-6
Jin, H., Ciechanowicz, A.K., Kaplan, A.R., Wang, L., Zhang, P.X., & Lu, Y.C., et al. (2018). Surfactant protein C dampens inflammation by decreasing JAK/STAT activation during lung repair. Am J Physiol Lung Cell Mol Physiol . 314(5), L882-L892. 10.1152/ajplung.00418.2017
Johnson, D.E., O’Keefe, R.A., & Grandis, J.R. (2018). Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol . 15(4), 234-248. 10.1038/nrclinonc.2018.8
Kim, B.H., Yi, E.H., Jee, J.G., Jeong, A.J., Sandoval, C., & Park, I.C., et al. (2020). Tubulosine selectively inhibits JAK3 signalling by binding to the ATP-binding site of the kinase of JAK3. J Cell Mol Med . 24(13), 7427-7438. 10.1111/jcmm.15362
Kumar, N., Mishra, J., Narang, V.S., & Waters, C.M. (2007). Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin. J Biol Chem . 282(42), 30341-30345. 10.1074/jbc.C600319200
Ladenburger, A., Seehase, M., Kramer, B.W., Thomas, W., Wirbelauer, J., Speer, C.P., & Kunzmann, S. (2010a). Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway. Am J Physiol Lung Cell Mol Physiol . 299(4), L578-L584. 10.1152/ajplung.00055.2010
Ladenburger, A., Seehase, M., Kramer, B.W., Thomas, W., Wirbelauer, J., Speer, C.P., & Kunzmann, S. (2010b). Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway. Am J Physiol Lung Cell Mol Physiol . 299(4), L578-L584. 10.1152/ajplung.00055.2010
Lee, H.S., & Lee, D.G. (2015). rIL-10 enhances IL-10 signalling proteins in foetal alveolar type II cells exposed to hyperoxia.Journal of Cellular & Molecular Medicine . 19(7), 1538-1547.
Li, J., Cao, C., Xiang, Y., Hong, Z., & Huang, X. (2020). TLT2 Suppresses Th1 Response by Promoting IL-6 Production in Monocyte Through JAK/STAT3 Signal Pathway in Tuberculosis. Frontiers in Immunology . 11, 2031.
Li, L., Xia, Y., Nguyen, A., Lai, Y.H., Feng, L., Mosmann, T.R., & Lo, D. (1999). Effects of Th2 Cytokines on Chemokine Expression in the Lung: IL-13 Potently Induces Eotaxin Expression by Airway Epithelial Cells.Journal of Immunology . 162(5), 2477.
Li, S.D., Ma, M., Li, H., Waluszko, A., Sidorenko, T., & Schadt, E.E., et al. (2017). Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications.Genome Med . 9(1), 89. 10.1186/s13073-017-0478-1
Li, W.X. (2008). Canonical and non-canonical JAK-STAT signaling.Trends Cell Biol . 18(11), 545-551. 10.1016/j.tcb.2008.08.008
Li, X., Zhang, Q., & Yang, Z. (2019). Silence of MEG3 intensifies lipopolysaccharide-stimulated damage of human lung cells through modulating miR-4262. Artif Cells Nanomed Biotechnol . 47(1), 2369-2378. 10.1080/21691401.2019.1623233
Li, Y., Wang, H., Wang, S., & Zhang, T. (2017). Effects of Ergosterol on COPD in Mice via JAK3/STAT3/NF-kappa B Pathway. Inflammation .
Liao, J., Fu, Y., & Shuai, K. (2000). Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction. Proc Natl Acad Sci U S A . 97(10), 5267-5272. 10.1073/pnas.97.10.5267
Liongue, C., Sertori, R., & Ward, A.C. (2016). Evolution of Cytokine Receptor Signaling. J Immunol . 197(1), 11-18. 10.4049/jimmunol.1600372
Liu, B., Gross, M., Ten, H.J., & Shuai, K. (2001). A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc Natl Acad Sci U S A . 98(6), 3203-3207. 10.1073/pnas.051489598
Liu, B., Liao, J., Rao, X., Kushner, S.A., Chung, C.D., Chang, D.D., & Shuai, K. (1998). Inhibition of Stat1-mediated gene activation by PIAS1.Proc Natl Acad Sci U S A . 95(18), 10626-10631. 10.1073/pnas.95.18.10626
Liu, J., & Kern, J.A. (2002). Neuregulin-1 Activates the JAK-STAT Pathway and Regulates Lung Epithelial Cell Proliferation. Am J Respir Cell Mol Biol . 27(3), 306-313.
Liu, W., Dong, M., Bo, L., Li, C., & Li, Z. (2015). Epigallocatechin-3-gallate Ameliorates Seawater Aspiration-Induced Acute Lung Injury via Regulating Inflammatory Cytokines and Inhibiting JAK/STAT1 Pathway in Rats. Mediators Inflamm . 2014(7), 612593.
Lundberg, P., Karow, A., Nienhold, R., Looser, R., Hao-Shen, H., & Nissen, I., et al. (2014). Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood . 123(14), 2220-2228. 10.1182/blood-2013-11-537167
Luo, W., Li, Y.X., Jiang, L.J., Chen, Q., Wang, T., & Ye, D.W. (2020). Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19. Trends in Pharmacological Sciences .
Matsumoto, A., Masuhara, M., Mitsui, K., Yokouchi, M., Ohtsubo, M., & Misawa, H., et al. (1997). CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.Blood . 89(9), 3148-3154.
Matthay, M.A. (2014). Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med . 189(11), 1301-1308. 10.1164/rccm.201403-0535OE
Matthay, M.A., Ware, L.B., & Zimmerman, G.A. (2012). The acute respiratory distress syndrome. J Clin Invest . 122(8), 2731-2740. 10.1172/JCI60331
McGonagle, D., Sharif, K., O’Regan, A., & Bridgewood, C. (2020). The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev . 19(6), 102537. 10.1016/j.autrev.2020.102537
Miklossy, G., Hilliard, T.S., & Turkson, J. (2013). Therapeutic modulators of STAT signalling for human diseases. Nat Rev Drug Discov . 12(8), 611-629. 10.1038/nrd4088
Mishra, J., Verma, R.K., Alpini, G., Meng, F., & Kumar, N. (2013). Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis. J Biol Chem . 288(44), 31795-31806. 10.1074/jbc.M113.504126
Mishra, J., & Kumar, N. (2014). Adapter protein Shc regulates Janus kinase 3 phosphorylation. J Biol Chem . 289(23), 15951-15956. 10.1074/jbc.C113.527523
Montero, P., Milara, J., Roger, I., & Cortijo, J. (2021). Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms. International Journal of Molecular Sciences . 22(12), 6211.
Morrell, E.D., Bhatraju, P.K., Mikacenic, C.R., Radella, F.N., Manicone, A.M., & Stapleton, R.D., et al. (2019). Alveolar Macrophage Transcriptional Programs Are Associated with Outcomes in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med . 200(6), 732-741. 10.1164/rccm.201807-1381OC
Nasreen, N., Gonzalves, L., Peruvemba, S., & Mohammed, K.A. (2014). Fluticasone furoate is more effective than mometasone furoate in restoring tobacco smoke inhibited SOCS-3 expression in airway epithelial cells. International Immunopharmacology . 19(1), 153-160.
Nicholson, S.E., De Souza, D., Fabri, L.J., Corbin, J., Willson, T.A., & Zhang, J.G., et al. (2000). Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A . 97(12), 6493-6498. 10.1073/pnas.100135197
Nuckton, T.J., Alonso, J.A., Kallet, R.H., Daniel, B.M., Pittet, J.F., Eisner, M.D., & Matthay, M.A. (2002). Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.N Engl J Med . 346(17), 1281-1286. 10.1056/NEJMoa012835
O’Shea, J.J., & Plenge, R. (2012). JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity . 36(4), 542-550. 10.1016/j.immuni.2012.03.014
Pandey, A., Fernandez, M.M., Steen, H., Blagoev, B., Nielsen, M.M., & Roche, S., et al. (2000). Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways. J Biol Chem . 275(49), 38633-38639. 10.1074/jbc.M007849200
Patoulias, D., Doumas, M., Papadopoulos, C., & Karagiannis, A. (2021). Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials.Clin Rheumatol . 10.1007/s10067-021-05884-4
Peter, A.E., Sandeep, B.V., Rao, B.G., & Kalpana, V.L. (2020). Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19. Front Pharmacol . 11, 583777. 10.3389/fphar.2020.583777
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., & Tao, Y., et al. (2020). Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis . 71(15), 762-768. 10.1093/cid/ciaa248
Radigan, K.A., Nicholson, T.T., Welch, L.C., Chi, M., Amarelle, L., & Angulo, M., et al. (2019). Influenza A Virus Infection Induces Muscle Wasting via IL-6 Regulation of the E3 Ubiquitin Ligase Atrogin-1.J Immunol . 202(2), 484-493. 10.4049/jimmunol.1701433
Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., Ferguson, N.D., Caldwell, E., & Fan, E., et al. (2012). Acute respiratory distress syndrome: the Berlin Definition. JAMA . 307(23), 2526-2533. 10.1001/jama.2012.5669
Rao, V.U., Pavlov, A., Klearman, M., Musselman, D., Giles, J.T., & Bathon, J.M., et al. (2015). An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol . 67(2), 372-380. 10.1002/art.38920
Raurich, J.M., Vilar, M., Colomar, A., Ibanez, J., Ayestaran, I., Perez-Barcena, J., & Llompart-Pou, J.A. (2010). Prognostic value of the pulmonary dead-space fraction during the early and intermediate phases of acute respiratory distress syndrome. Respir Care . 55(3), 282-287.
Rawlings, J.S., Rosler, K.M., & Harrison, D.A. (2004). The JAK/STAT signaling pathway. J Cell Sci . 117(Pt 8), 1281-1283. 10.1242/jcs.00963
Riviello, E.D., Kiviri, W., Twagirumugabe, T., Mueller, A., Banner-Goodspeed, V.M., & Officer, L., et al. (2016). Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition. Am J Respir Crit Care Med . 193(1), 52-59. 10.1164/rccm.201503-0584OC
Rubenfeld, G.D., Caldwell, E., Peabody, E., Weaver, J., Martin, D.P., & Neff, M., et al. (2005). Incidence and outcomes of acute lung injury.N Engl J Med . 353(16), 1685-1693. 10.1056/NEJMoa050333
Saber-Ayad, M., Hammoudeh, S., Abu-Gharbieh, E., Hamoudi, R., Tarazi, H., Al-Tel, T.H., & Hamid, Q. (2021). Current Status of Baricitinib as a Repurposed Therapy for COVID-19. Pharmaceuticals (Basel) . 14(7). 10.3390/ph14070680
Sada, M., Watanabe, M., Nakamoto, K., Inui, T., & Takizawa, H. (2020). Ruxolitinib inhibits poly (I:C) and IL-13-induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma.
Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., & Kinjyo, I., et al. (1999). Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells . 4(6), 339-351. 10.1046/j.1365-2443.1999.00263.x
Saxena, N.K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., & Anania, F.A. (2007). Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res . 67(6), 2497-2507. 10.1158/0008-5472.CAN-06-3075
Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P.C., & Schaper, F. (2000). SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem . 275(17), 12848-12856. 10.1074/jbc.275.17.12848
Sen, M., & Grandis, J.R. (2012). Nucleic acid-based approaches to STAT inhibition. JAKSTAT . 1(4), 285-291. 10.4161/jkst.22312
Severgnini, M., Takahashi, S., Rozo, L.M., Homer, R.J., Kuhn, C., & Jhung, J.W., et al. (2004). Activation of the STAT pathway in acute lung injury. Am J Physiol Lung Cell Mol Physiol . 286(6), L1282-L1292. 10.1152/ajplung.00349.2003
Severgnini, M., Takahashi, S., Tu, P., Perides, G., Homer, R.J., & Jhung, J.W., et al. (2005a). Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med . 171(8), 858-867. 10.1164/rccm.200407-981OC
Severgnini, M., Takahashi, S., Tu, P., Perides, G., Homer, R.J., & Jhung, J.W., et al. (2005b). Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med . 171(8), 858-867. 10.1164/rccm.200407-981OC
Shaikh, S.B., Bhat, S.G., & Bhandary, Y.P. (2020). Curcumin attenuates IL-17A mediated pulmonary SMAD dependent and non-dependent mechanism during acute lung injury in vivo. Mol Biol Rep . 47(7), 5643-5649. 10.1007/s11033-020-05587-0
Shuai, K., Stark, G.R., Kerr, I.M., & Darnell, J.J. (1993). A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science . 261(5129), 1744-1746. 10.1126/science.7690989
Simon, A.R., Rai, U., Fanburg, B.L., & Cochran, B.H. (1998). Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol . 275(6), C1640-C1652. 10.1152/ajpcell.1998.275.6.C1640
Singh, D., Bogus, M., Moskalenko, V., Lord, R., Moran, E.J., & Crater, G.D., et al. (2021). A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.Eur Respir J . 58(4). 10.1183/13993003.00673-2021
Song, Z., Zhao, X., Gao, Y., Liu, M., Hou, M., Jin, H., & Cui, Y. (2015). Recombinant human brain natriuretic peptide ameliorates trauma-induced acute lung injury via inhibiting JAK/STAT signaling pathway in rats. Journal of Trauma & Acute Care Surgery . 78(5), 980-987.
Sopjani, M., Thaci, S., Krasniqi, B., Selmonaj, M., Rinnerthaler, M., & Dermaku-Sopjani, M. (2017). Regulation of Ion Channels, Cellular Carriers and Na(+)/K(+)/ATPase by Janus Kinase 3. Curr Med Chem . 24(21), 2251-2260. 10.2174/0929867324666170203122625
Spragg, R.G., Lewis, J.F., Walmrath, H.D., Johannigman, J., Bellingan, G., & Laterre, P.F., et al. (2004). Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med . 351(9), 884-892. 10.1056/NEJMoa033181
Tahk, S., Liu, B., Chernishof, V., Wong, K.A., Wu, H., & Shuai, K. (2007). Control of specificity and magnitude of NF-kappa B and STAT1-mediated gene activation through PIASy and PIAS1 cooperation.Proc Natl Acad Sci U S A . 104(28), 11643-11648. 10.1073/pnas.0701877104
Takahashi, T., & Shirasaw, T. (1994). Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases. Febs Letters . 342(2), 124.
Talukdar, J., Bhadra, B., Dattaroy, T., Nagle, V., & Dasgupta, S. (2020). Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19. Biomed Pharmacother . 132, 110886. 10.1016/j.biopha.2020.110886
Tang, Y., Liu, W., Wang, W., Fidler, T., Woods, B., & Levine, R.L., et al. (2020). Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe(-/-) Mice. Cardiovasc Drugs Ther . 34(2), 145-152. 10.1007/s10557-020-06943-9
Tuttle, K.R., Brosius, F.R., Adler, S.G., Kretzler, M., Mehta, R.L., & Tumlin, J.A., et al. (2018). JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial. Nephrol Dial Transplant . 33(11), 1950-1959. 10.1093/ndt/gfx377
Waldmann, T.A., & Chen, J. (2017). Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy. Annu Rev Immunol . 35, 533-550. 10.1146/annurev-immunol-110416-120628
Wang, Y., Gao, T.T., Xu, D.F., Zhu, X.Y., Dong, W.W., & Lv, Z., et al. (2019). Upregulation of sphingosine kinase 1 contributes to ventilator-associated lung injury in a two-hit model. Int J Mol Med . 44(6), 2077-2090. 10.3892/ijmm.2019.4379
Wang, Y.C., Cui, X.B., Chuang, Y.H., & Chen, S.Y. (2017a). Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.Arterioscler Thromb Vasc Biol . 37(7), 1352-1360. 10.1161/ATVBAHA.116.308895
Wang, Y.C., Cui, X.B., Chuang, Y.H., & Chen, S.Y. (2017b). Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling. Arterioscler Thromb Vasc Biol . 37(7), 1352-1360. 10.1161/ATVBAHA.116.308895
Wit, J.M., & de Luca, F. (2016). Atypical defects resulting in growth hormone insensitivity. Growth Horm IGF Res . 28, 57-61. 10.1016/j.ghir.2015.11.005
Wollenhaupt, J., Lee, E.B., Curtis, J.R., Silverfield, J., Terry, K., & Soma, K., et al. (2019). Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study. Arthritis Res Ther . 21(1), 89. 10.1186/s13075-019-1866-2
Xu, D., & Qu, C.K. (2008). Protein tyrosine phosphatases in the JAK/STAT pathway. Front Biosci . 13, 4925-4932. 10.2741/3051
Yadav, H., Thompson, B.T., & Gajic, O. (2017). Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?Am J Respir Crit Care Med . 195(6), 725-736. 10.1164/rccm.201609-1767CI
Yadav, U., Leopoldo, A.A., Ramana, K.V., Istvan, B., Srivastava, S.K., & Melanie, K. (2010). Aldose Reductase Inhibition Prevents Metaplasia of Airway Epithelial Cells. Plos One . 5(12), e14440.
Yamada, S., Shiono, S., Joo, A., & Yoshimura, A. (2003). Control mechanism of JAK/STAT signal transduction pathway. FEBS Lett . 534(1-3), 190-196. 10.1016/s0014-5793(02)03842-5
Yan, C., Naltner, A., Martin, M., Naltner, M., Fangman, J.M., & Gurel, O. (2002). Transcriptional Stimulation of the Surfactant Protein B Gene by STAT3 in Respiratory Epithelial Cells. Journal of Biological Chemistry . 277(13), 10967-10972.
Yang, X., Jia, J., Yu, Z., Duanmu, Z., He, H., Chen, S., & Qu, C. (2020). Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit. BMC Cardiovasc Disord . 20(1), 133. 10.1186/s12872-020-01391-7
Ying, Z.H., Li, H.M., Yu, W.Y., & Yu, C.H. (2021). Iridin Prevented Against Lipopolysaccharide-Induced Inflammatory Responses of Macrophages via Inactivation of PKM2-Mediated Glycolytic Pathways. Journal of Inflammation Research . Volume 14, 341-354.
Yoshihiko, C., Kumiko, G., & Miwa, M. (2012). Interleukin-13-induced activation of signal transducer and activator of transcription 6 is mediated by an activation of Janus kinase 1 in cultured human bronchial smooth muscle cells. Pharmacological Reports . 64(2), 454-458.
Yoshimura, A. (1998a). The CIS family: negative regulators of JAK-STAT signaling. Cytokine Growth Factor Rev . 9(3-4), 197-204. 10.1016/s1359-6101(98)00019-7
Yoshimura, A. (1998b). The CIS/JAB family: novel negative regulators of JAK signaling pathways. Leukemia . 12(12), 1851-1857. 10.1038/sj.leu.2401238
Yu, Q., Shi, Y.J., Shu, C., Ding, X.C., & Lou, Y.F. (2021). Andrographolide Inhibition of Th17-Regulated Cytokines and JAK1/STAT3 Signaling in OVA-Stimulated Asthma in Mice. Evidence-based Complementary and Alternative Medicine . 2021(11), 1-11.
Yz, A., Xu, Z.A., Cw, A., Xs, B., Hs, A., & Tm, C., et al. Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis - ScienceDirect. Bioorganic & Medicinal Chemistry . 28(2).
Zetterberg, C., Maltais, F., Laitinen, L., Liao, S., Tsao, H., Chakilam, A., & Hariparsad, N. (2016). VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions. Drug Metab Dispos . 44(8), 1286-1295. 10.1124/dmd.116.071100
Zhao, J., Yu, H., Liu, Y., Gibson, S.A., Yan, Z., & Xu, X., et al. (2016). Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol . 311(5), L868-L880. 10.1152/ajplung.00281.2016
Zhou, M., Zhuo, L., & Cai, C. (2018). Astragaloside IV Inhibits Cigarette Smoke-Induced Pulmonary Inflammation in Mice.Inflammation , 1-10.
Zhou, Y., Wang, M., Li, Y., Wang, P., & Hou, J. (2021). SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium. Immunology Letters . 237(10224).
Zhu, J., Yamane, H., & Paul, W.E. (2010). Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol . 28, 445-489. 10.1146/annurev-immunol-030409-101212
Zhu, M.X., Huang, L.H., Zhu, Y.K., & Cai, X.J. LncRNA NEAT1 promotes airway smooth muscle cell inflammation by activating the JAK3/STAT5 pathway through targeting of miR-139. Experimental lung research . 47(4), 161-172.
Zhu, Y., Zheng, X., Wang, C., Sun, X., Sun, H., & Ma, T., et al. (2020). Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis. Bioorg Med Chem . 28(2), 115254. 10.1016/j.bmc.2019.115254
TABLE 1 The 2021 Berlin definition of ARDS.